Clinical trials
Active, not recruiting Phase 2 Thyroid Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 7 |
| 2021 | 3 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 5 |
| National Cancer Institute (NCI) | 5 |
| Memorial Sloan Kettering Cancer Center | 4 |
| Eli Lilly and Company | 1 |
| Instituto do Cancer do Estado de São Paulo | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Providence Health & Services | 1 |
| SOLTI Breast Cancer Research Group | 1 |
| Saad A Khan | 1 |
| University of Chicago | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Neoplasms | 21 |
| Thyroid Cancer, Papillary | 5 |
| Cholangiocarcinoma | 4 |
| Melanoma | 4 |
| Sarcoma | 4 |
| Thyroid Carcinoma, Anaplastic | 4 |
| Adenocarcinoma, Follicular | 3 |
| Anus Neoplasms | 3 |
| Carcinoma, Renal Cell | 3 |
| Mesothelioma | 3 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.